BioMarin Pharmaceutical Inc. (BIT:1BMRN)
Italy · Delayed Price · Currency is EUR 45.84
-0.43 (-0.93%)
At close: Dec 5, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €8.82 billion as of December 5, 2025. Its market cap has decreased by -20.94% in one year.
Market Cap
8.82B
Enterprise Value
8.07B
Revenue
2.64B
Ranking
n/a
PE Ratio
19.88
Stock Price
€45.84
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.82B, an increase of 1,971.93%. That is a compound annual growth rate of 12.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.82B | -27.12% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | 13.01B | -3.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 102.35B |
| Intesa Sanpaolo | 97.66B |
| Enel SpA | 88.88B |
| Ferrari | 60.02B |
| Assicurazioni Generali | 51.26B |
| Eni S.p.A. | 49.59B |
| Stellantis | 29.42B |
| Leonardo S.p.a. | 27.29B |